MINT-SPIRONOLACTONE
MINT-SPIRONOLACTONE
Approved
DIN Number
02488159
Drug Class
Human
Market Date
Feb 6, 2020
Company
HC
mint pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02488159
AIG Number0106462002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03DA01 SPIRONOLACTONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
SPIRONOLACTONEActive
Strength: 100 MG
Monograph: SPIRONOLACTONE